Replacement Heart Update
July 10, 2001
Drs. Gray and Dowling, the patient's surgical team,
have indicated that the patient continues to rest comfortably and
his progress is consistent with prior expectations. Further information
will be made available only when there is a significant change in
condition or when meaningful clinical milestones are reached.
Future Media Inquiries
Jewish Hospital, the University of Louisville and
ABIOMED have indicated that they would enforce a "quiet period"
with regard to the recent implant of the AbioCor Implantable
Replacement Heart. This quiet period is intended to protect and
respect the privacy and confidentiality of the patient and his family.
We urge members of the media to understand and respect this policy.
In recognition of the numerous calls and inquiries concerning the
technical facets of the AbioCor and of the surgical procedure, and
the "well wishes" sent to the patient and his family,
Jewish Hospital, the University of Louisville and ABIOMED have agreed
that we will receive questions via our
media center at (502) 561-5447. Answers to questions
will be obtained from appropriate parties at the various institutions,
and questions and answers will be posted on our websites at heartpioneers.com
and abiomed.com. Please note that we will not respond to questions
regarding the patient's clinical condition, or to questions that
would infringe upon the privacy of the patient or his family.
We appreciate very much the interest being shown in
this project. We also hope that members of the media can appreciate
and respect our desire to conduct this clinical trial in an ethical
manner, respecting above all the dignity and privacy of the patient
and his family.
Acrobat Reader Required)